Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
As of today, Abbott(ABT) shares are valued at $90.56. The company's market cap stands at 157.72B, with a P/E ratio of 25.44 and a dividend yield of 2.6%.
On 2026-04-30, Abbott(ABT) stock moved within a range of $90.29 to $91.75. With shares now at $90.56, the stock is trading +0.3% above its intraday low and -1.3% below the session's peak.
Trading volume for Abbott(ABT) stock has reached 4.63M, versus its average volume of 14.55M.
The stock's 52-week range extends from a low of $90.29 to a high of $139.06.
The stock's 52-week range extends from a low of $90.29 to a high of $139.06.
ABT News
Abbott Laboratories (NYSE:ABT) received U.S. FDA clearance and CE Mark for its AI powered Ultreon 3.0 Software. Ultreon 3.0 is a next generation coronary imagi...
New insider activity at Abbott Laboratories ( (ABT) ) has taken place on April 28, 2026. Unlock hedge fund-level data and powerful investing tools for smarter,...
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at tw...
Analyst ratings
75%
of 32 ratingsMore ABT News
Key Points Abbott Laboratories is a very diversified company, which can reduce some risks. The medical products maker is a committed dividend payer, too, with...
Abbott (ABT) received FDA clearance and CE Mark for its Ultreon 3.0 Software. Ultreon 3.0 is an AI powered imaging platform that uses optical coherence tomograp...
In April 2026, Abbott Laboratories reported late-breaking data from four trials in its pulsed field ablation and conduction system pacing portfolios, highlighti...
The average one-year price target for Abbott Laboratories (BIT:1ABT) has been revised to €102.05 / share. This is a decrease of 10.05% from the prior estimate o...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.